FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895431602> ?p ?o ?g. }

• W2895431602 endingPage "e4882" @default.
• W2895431602 startingPage "e4882" @default.
• W2895431602 abstract "In this study, we describe clinical and imaging spectrum, and the natural course of patients with disseminated cysticercosis. How albendazole affects the course of disease has also been evaluated. We assessed the Toll-like receptor-4 gene polymorphisms, to know the reason for the apparently higher prevalence of disseminated cysticercosis in India. Sixty consecutive patients with disseminated cysticercosis were enrolled. Sixty age-and-sex-matched healthy controls were also enrolled for the purpose of genetic study. Twenty patients, who gave consent, were treated with albendazole along with corticosteroids. Forty patients did not give consent for antiparasitic therapy. Assessment for Toll-like receptor-4 gene polymorphisms (Asp299Gly and Thr399Ile genes) was done. Patients were followed for 6 months. We also performed a literature search of cases published in English language using PubMed electronic database and analyzed 56 cases thus available. There was an increased risk (6.63 fold and 4.61 fold) of disseminated cysticercosis in the presence of Asp299Gly and Thr399Ile polymorphisms in Toll-like receptor-4, respectively. The allelic frequency of Gly (11% vs. 3%, P = 0.024, odds ratio [OR] = 3.52) and Ile alleles (11% vs. 2%, P = 0.009, OR = 4.738) in disseminated cysticercosis was high. Albendazole resulted in complete disappearance of all cerebral lesions in 35% (7/20) patients and reduction in lesion load in remaining 65% (13/20) patients. No significant change in number of cysticercal lesion was noted in patients who did not receive albendazole. No major adverse reaction following antiparasitic treatment was noted. Three deaths were recorded in patients who did not receive antiparasitic treatment. Of the 56 cases reported in PubMed, 33 patients received antiparasitic treatment with follow-up data available for 31 patients. Most (24) of these patients received albendazole. A significant clinical and/or imaging improvements, on follow up, were observed in 27 patients. Of the 4 deaths recorded, 3 had a heavy parasitic load and died after praziquantel therapy. Toll-like receptor-4 gene polymorphisms are associated with an increased susceptibility to disseminated cysticercosis, in the Indian population. Albendazole treatment seems to reduce the lesion load and improve symptoms." @default.
• W2895431602 created "2018-10-12" @default.
• W2895431602 creator A5003355669 @default.
• W2895431602 creator A5012417018 @default.
• W2895431602 creator A5019254531 @default.
• W2895431602 creator A5029777498 @default.
• W2895431602 creator A5044112149 @default.
• W2895431602 creator A5068937919 @default.
• W2895431602 creator A5075835948 @default.
• W2895431602 creator A5079670229 @default.
• W2895431602 creator A5088529972 @default.
• W2895431602 date "2016-09-01" @default.
• W2895431602 modified "2023-10-16" @default.
• W2895431602 title "Disseminated cysticercosis" @default.
• W2895431602 cites W1567261778 @default.
• W2895431602 cites W1937318213 @default.
• W2895431602 cites W1977587133 @default.
• W2895431602 cites W1983307460 @default.
• W2895431602 cites W2000371334 @default.
• W2895431602 cites W2032089916 @default.
• W2895431602 cites W2036094133 @default.
• W2895431602 cites W2051366104 @default.
• W2895431602 cites W2063081141 @default.
• W2895431602 cites W2101023609 @default.
• W2895431602 cites W2113672069 @default.
• W2895431602 cites W2116049180 @default.
• W2895431602 cites W2118094114 @default.
• W2895431602 cites W2125910347 @default.
• W2895431602 cites W2143796522 @default.
• W2895431602 cites W2155834926 @default.
• W2895431602 cites W2160859576 @default.
• W2895431602 cites W2418192925 @default.
• W2895431602 cites W4212826141 @default.
• W2895431602 cites W4237163308 @default.
• W2895431602 cites W4368046676 @default.
• W2895431602 doi "https://doi.org/10.1097/md.0000000000004882" @default.
• W2895431602 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5265915" @default.
• W2895431602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27684822" @default.
• W2895431602 hasPublicationYear "2016" @default.
• W2895431602 type Work @default.
• W2895431602 sameAs 2895431602 @default.
• W2895431602 citedByCount "21" @default.
• W2895431602 countsByYear W28954316022018 @default.
• W2895431602 countsByYear W28954316022019 @default.
• W2895431602 countsByYear W28954316022020 @default.
• W2895431602 countsByYear W28954316022021 @default.
• W2895431602 countsByYear W28954316022022 @default.
• W2895431602 countsByYear W28954316022023 @default.
• W2895431602 crossrefType "journal-article" @default.
• W2895431602 hasAuthorship W2895431602A5003355669 @default.
• W2895431602 hasAuthorship W2895431602A5012417018 @default.
• W2895431602 hasAuthorship W2895431602A5019254531 @default.
• W2895431602 hasAuthorship W2895431602A5029777498 @default.
• W2895431602 hasAuthorship W2895431602A5044112149 @default.
• W2895431602 hasAuthorship W2895431602A5068937919 @default.
• W2895431602 hasAuthorship W2895431602A5075835948 @default.
• W2895431602 hasAuthorship W2895431602A5079670229 @default.
• W2895431602 hasAuthorship W2895431602A5088529972 @default.
• W2895431602 hasBestOaLocation W28954316021 @default.
• W2895431602 hasConcept C126322002 @default.
• W2895431602 hasConcept C141071460 @default.
• W2895431602 hasConcept C142724271 @default.
• W2895431602 hasConcept C156957248 @default.
• W2895431602 hasConcept C2777065887 @default.
• W2895431602 hasConcept C2778056992 @default.
• W2895431602 hasConcept C2779726973 @default.
• W2895431602 hasConcept C2781156865 @default.
• W2895431602 hasConcept C71924100 @default.
• W2895431602 hasConcept C90924648 @default.
• W2895431602 hasConceptScore W2895431602C126322002 @default.
• W2895431602 hasConceptScore W2895431602C141071460 @default.
• W2895431602 hasConceptScore W2895431602C142724271 @default.
• W2895431602 hasConceptScore W2895431602C156957248 @default.
• W2895431602 hasConceptScore W2895431602C2777065887 @default.
• W2895431602 hasConceptScore W2895431602C2778056992 @default.
• W2895431602 hasConceptScore W2895431602C2779726973 @default.
• W2895431602 hasConceptScore W2895431602C2781156865 @default.
• W2895431602 hasConceptScore W2895431602C71924100 @default.
• W2895431602 hasConceptScore W2895431602C90924648 @default.
• W2895431602 hasIssue "39" @default.
• W2895431602 hasLocation W28954316021 @default.
• W2895431602 hasLocation W28954316022 @default.
• W2895431602 hasLocation W28954316023 @default.
• W2895431602 hasLocation W28954316024 @default.
• W2895431602 hasOpenAccess W2895431602 @default.
• W2895431602 hasPrimaryLocation W28954316021 @default.
• W2895431602 hasRelatedWork W1496221933 @default.
• W2895431602 hasRelatedWork W161545708 @default.
• W2895431602 hasRelatedWork W1668755745 @default.
• W2895431602 hasRelatedWork W2001235835 @default.
• W2895431602 hasRelatedWork W2049031436 @default.
• W2895431602 hasRelatedWork W2157484860 @default.
• W2895431602 hasRelatedWork W2284513876 @default.
• W2895431602 hasRelatedWork W2350901706 @default.
• W2895431602 hasRelatedWork W2405393991 @default.
• W2895431602 hasRelatedWork W2394666912 @default.
• W2895431602 hasVolume "95" @default.
• W2895431602 isParatext "false" @default.

• next